| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.05. | RAPT Therapeutics, Inc. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| 09.05. | RAPT Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.04. | RAPT Therapeutics, Inc.: RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients | 154 | GlobeNewswire (Europe) | - Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status - Confirmed ORR of 17.4% in subset of patients with PD-L1+ disease - Confirmed ORR of 22.2% in... ► Artikel lesen | |
| 07.03. | RAPT Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 07.03. | RAPT Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 07.03. | RAPT Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.03. | RAPT Therapeutics, Inc.: RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results | 163 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and... ► Artikel lesen | |
| 05.03. | RAPT Therapeutics, Inc.: RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting | 27 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and... ► Artikel lesen | |
| 20.02. | RAPT Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 20.02. | RAPT Therapeutics, Inc.: RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon | 621 | GlobeNewswire (Europe) | - RAPT to host a conference call today at 8:30 am ET - SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 327 |
| EVOTEC | 291 |
| TUI | 209 |
| NVIDIA | 177 |
| DEUTSCHE BANK | 170 |
| BAYER | 154 |
| PLUG POWER | 143 |
| NEL | 133 |
| RHEINMETALL | 129 |
| SIEMENS ENERGY | 110 |
| BARRICK GOLD | 109 |
| COMMERZBANK | 107 |
| TESLA | 102 |
| BASF | 101 |
| VOLKSWAGEN | 93 |
| RWE | 89 |
| BYD | 87 |
| DEUTSCHE LUFTHANSA | 84 |
| ALLIANZ | 82 |
| RENK GROUP | 79 |
| MERCEDES-BENZ | 78 |
| DEUTSCHE TELEKOM | 75 |
| HEIDELBERGER DRUCK | 75 |
| ALIBABA | 71 |
| E.ON | 69 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
